Innovating Medicines for a Healthier Tomorrow
Egbogi Therapeutics is building Nigeria's capacity to manufacture essential medicine ingredients locally, and to discover new medicines from African science.
Advancing Science. Improving Lives.
10 kg
Pilot Reactor Scale
Per-batch capacity of our microwave pilot
≥99%
Target Purity
Benchmarked against USP reference standards
Next Industrial Milestone
Scaling microwave synthesis toward commercial production
500 kg
Flagship Antimalarial Target
Plasmodial transketolase inhibitor discovery
1
WHY EGBOGI?
The medicine is made here. The ingredients aren’t.
Most of the active ingredients behind everyday medicines are imported. That leaves Nigerian manufacturers exposed to currency swings, long supply chains and disruption abroad. Egbogi Therapeutics is changing that, with locally developed technology, original research and a new generation of African scientists.
1
Local Supply
From imported to made in Nigeria
Most active ingredients behind everyday medicines come from abroad. We’re building the capacity to make them here, starting with paracetamol.
2
Original Science
Antimalarial discovery programme
We combine computational design, synthesis, biological testing and structural biology to find medicines for the diseases that hit Africa hardest.
3
Trained Talent
Academy, coming soon
The proposed Egbogi Academy trains scientists in drug design and industrial-scale process chemistry, so the capability stays in Africa.
From Research to Real-World Impact
API Manufacturing
Drug Discovery
Microwave Technology
Egbogi Academy
Platform I | API manufacturing
Made in Nigeria, from the first molecule.
We're building a local platform to produce active pharmaceutical ingredients, starting with paracetamol. Our microwave reactors make reactions faster and cleaner, and they're built to scale from pilot batches to industrial production.
Raw material feed
Microwave Reactor
Cooling and Quench
Filtration and Wash
Drying and Packing
Platform II | Drug Discovery
Discovering the next generation of antimalarials.
One workflow joins computational design, organic synthesis, biological testing and structural biology. Our flagship programme targets plasmodial transketolase, aiming to hit the parasite and spare the human enzyme.
1. Design
2. Synthesise
3. Test
4. Validate
Scientific leadership
Dr. A.O Fadare
Associate Professor of Chemistry, Obafemi Awolowo University
Business leadership
Taiwo Okeyedun
Organic synthesis researcher, University of Alberta
Strategic leadership
Third co-founder
Name to be confirmed by the client
Let's build Africa's pharmaceutical future together.
Research partners, manufacturers, investors and institutions: we'd like to hear from you.
Let's build Africa's Pharmaceutical future together.
Research partners, manufacturers, investors and institutions: we'd like to hear from you.